<!DOCTYPE html>
<html>
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<meta http-equiv="X-UA-Compatible" content="ie=edge">
<title>Markmap</title>
<style>
* {
  margin: 0;
  padding: 0;
}
#mindmap {
  display: block;
  width: 100vw;
  height: 100vh;
}
</style>
<link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/markmap-toolbar@0.18.10/dist/style.css">
</head>
<body>
<svg id="mindmap"></svg>
<script src="https://cdn.jsdelivr.net/npm/d3@7.9.0/dist/d3.min.js"></script><script src="https://cdn.jsdelivr.net/npm/markmap-view@0.18.10/dist/browser/index.js"></script><script src="https://cdn.jsdelivr.net/npm/markmap-toolbar@0.18.10/dist/index.js"></script><script>(()=>{setTimeout(()=>{const{markmap:x,mm:K}=window,P=new x.Toolbar;P.attach(K);const F=P.render();F.setAttribute("style","position:absolute;bottom:20px;right:20px"),document.body.append(F)})})()</script><script>((b,L,T,D)=>{const H=b();window.mm=H.Markmap.create("svg#mindmap",(L||H.deriveOptions)(D),T)})(()=>window.markmap,null,{"content":"","children":[{"content":"Chemical injury: assessment","children":[{"content":"Prognostic factors","children":[{"content":"Prognostic clinical features are summarized in the Roper-Hall and Dua classifications","children":[],"payload":{"tag":"li","lines":"15,16"}},{"content":"Severity is determined by:","children":[{"content":"pH: alkaline agents generally cause more severe injuries","children":[],"payload":{"tag":"li","lines":"17,18"}},{"content":"Duration of contact","children":[],"payload":{"tag":"li","lines":"18,19"}},{"content":"Corneal involvement: surface area and duration","children":[],"payload":{"tag":"li","lines":"19,20"}},{"content":"Limbal involvement: crucial for re-epithelialization from limbal stem cells","children":[],"payload":{"tag":"li","lines":"20,21"}},{"content":"Conjunctival involvement: conjunctivalization occurs if limbal stem cells are destroyed","children":[],"payload":{"tag":"li","lines":"21,22"}},{"content":"Chemical retention in conjunctival fornix may cause continued damage","children":[],"payload":{"tag":"li","lines":"22,23"}},{"content":"Associated non-chemical injury (e.g., blunt or thermal trauma)","children":[],"payload":{"tag":"li","lines":"23,25"}}],"payload":{"tag":"li","lines":"16,25"}}],"payload":{"tag":"h2","lines":"13,14"}},{"content":"Clinical features","children":[{"content":"Conjunctival inflammation (red eye) or ischaemia (beware &#x2018;white&#x2019; eye)","children":[],"payload":{"tag":"li","lines":"27,28"}},{"content":"&#xb1; chemosis, haemorrhage, epithelial defects, ulceration, necrosis, or loss of conjunctiva","children":[],"payload":{"tag":"li","lines":"28,29"}},{"content":"Perilimbal ischaemia: blanched vessels with no visible blood flow","children":[],"payload":{"tag":"li","lines":"29,30"}},{"content":"Corneal epitheliopathy (from punctate to complete loss; may stain poorly with fluorescein)","children":[],"payload":{"tag":"li","lines":"30,31"}},{"content":"Corneal oedema, stromal necrosis","children":[],"payload":{"tag":"li","lines":"31,32"}},{"content":"Anterior chamber (AC) activity and fibrin","children":[],"payload":{"tag":"li","lines":"32,33"}},{"content":"Traumatic mydriasis","children":[],"payload":{"tag":"li","lines":"33,34"}},{"content":"Increased IOP (use Icare&#xae; or Tono-Pen&#xae;, avoid Goldmann)","children":[],"payload":{"tag":"li","lines":"34,35"}},{"content":"Rare: scleral necrosis, vitritis, necrotic retinopathy","children":[],"payload":{"tag":"li","lines":"35,37"}}],"payload":{"tag":"h2","lines":"25,26"}},{"content":"Complications","children":[{"content":"Conjunctival burns: cicatrization, symblepharon, ankyloblepharon, goblet cell loss, keratinization","children":[],"payload":{"tag":"li","lines":"39,40"}},{"content":"Significant limbal ischaemia: leads to conjunctivalization, vascularization, and opacification","children":[],"payload":{"tag":"li","lines":"40,41"}},{"content":"Full-thickness burns: risk of scleritis, vitritis, retinitis, optic neuropathy, hypotony, iris and lens damage &#x2192; may progress to phthisis bulbi","children":[],"payload":{"tag":"li","lines":"41,42"}},{"content":"Periorbital burns: may lead to corneal exposure from lid contractures","children":[],"payload":{"tag":"li","lines":"42,43"}},{"content":"Ensure follow-up in 1&#x2013;2 weeks, even if globe injury absent","children":[],"payload":{"tag":"li","lines":"43,45"}}],"payload":{"tag":"h2","lines":"37,38"}},{"content":"Table 3.4 Roper-Hall classification of ocular surface burns","children":[{"content":"<table data-lines=\"47,53\">\n<thead data-lines=\"47,48\">\n<tr data-lines=\"47,48\">\n<th>Grade</th>\n<th>Corneal appearance</th>\n<th>Limbal ischaemia</th>\n<th>Prognosis</th>\n</tr>\n</thead>\n<tbody data-lines=\"49,53\">\n<tr data-lines=\"49,50\">\n<td>I</td>\n<td>Clear cornea</td>\n<td>Nil</td>\n<td>Good</td>\n</tr>\n<tr data-lines=\"50,51\">\n<td>II</td>\n<td>Hazy cornea, iris visible</td>\n<td>&lt;1/3</td>\n<td>Good</td>\n</tr>\n<tr data-lines=\"51,52\">\n<td>III</td>\n<td>Opaque cornea, iris obscured</td>\n<td>1/3&#x2013;1/2</td>\n<td>Guarded</td>\n</tr>\n<tr data-lines=\"52,53\">\n<td>IV</td>\n<td>Opaque cornea, iris obscured</td>\n<td>&gt;1/2</td>\n<td>Poor</td>\n</tr>\n</tbody>\n</table>","children":[],"payload":{"tag":"table","lines":"47,53"}}],"payload":{"tag":"h2","lines":"45,46"}},{"content":"Table 3.5 Dua classification of ocular surface burns","children":[{"content":"<table data-lines=\"56,64\">\n<thead data-lines=\"56,57\">\n<tr data-lines=\"56,57\">\n<th>Grade</th>\n<th>Limbal involvement (hrs)</th>\n<th>Conjunctival involvement (%)</th>\n<th>Prognosis</th>\n</tr>\n</thead>\n<tbody data-lines=\"58,64\">\n<tr data-lines=\"58,59\">\n<td>I</td>\n<td>0</td>\n<td>0</td>\n<td>Very good</td>\n</tr>\n<tr data-lines=\"59,60\">\n<td>II</td>\n<td>&#x2264;3</td>\n<td>&#x2264;30</td>\n<td>Good</td>\n</tr>\n<tr data-lines=\"60,61\">\n<td>III</td>\n<td>&gt;3&#x2013;6</td>\n<td>&gt;30&#x2013;50</td>\n<td>Good</td>\n</tr>\n<tr data-lines=\"61,62\">\n<td>IV</td>\n<td>&gt;6&#x2013;9</td>\n<td>&gt;50&#x2013;75</td>\n<td>Good to guarded</td>\n</tr>\n<tr data-lines=\"62,63\">\n<td>V</td>\n<td>&gt;9&#x2013;12</td>\n<td>&gt;75&#x2013;&lt;100</td>\n<td>Guarded to poor</td>\n</tr>\n<tr data-lines=\"63,64\">\n<td>VI</td>\n<td>12 (total)</td>\n<td>100 (total)</td>\n<td>Very poor</td>\n</tr>\n</tbody>\n</table>","children":[],"payload":{"tag":"table","lines":"56,64"}}],"payload":{"tag":"h2","lines":"54,55"}}],"payload":{"tag":"h1","lines":"5,6"}},{"content":"Chemical injury: treatment","children":[{"content":"Immediate","children":[{"content":"Irrigation protocol","children":[{"content":"Test pH","children":[],"payload":{"tag":"li","lines":"77,78"}},{"content":"Instill topical anaesthetic (e.g., proxymetacaine)","children":[],"payload":{"tag":"li","lines":"78,79"}},{"content":"Use speculum if available","children":[],"payload":{"tag":"li","lines":"79,80"}},{"content":"Irrigate with:","children":[{"content":"Water","children":[],"payload":{"tag":"li","lines":"81,82"}},{"content":"Normal saline","children":[],"payload":{"tag":"li","lines":"82,83"}},{"content":"Diphoterine&#xae;","children":[],"payload":{"tag":"li","lines":"83,84"}},{"content":"Hartmann&#x2019;s solution","children":[],"payload":{"tag":"li","lines":"84,85"}}],"payload":{"tag":"li","lines":"80,85"}},{"content":"Use IV tubing to deliver minimum 2L, or until normal pH restored","children":[],"payload":{"tag":"li","lines":"85,86"}},{"content":"Do not delay irrigation to obtain anything other than water","children":[],"payload":{"tag":"li","lines":"86,88"}}],"payload":{"tag":"h3","lines":"75,76"}},{"content":"Inspection","children":[{"content":"Evert and double-evert lids","children":[],"payload":{"tag":"li","lines":"90,91"}},{"content":"Inspect fornices","children":[],"payload":{"tag":"li","lines":"91,92"}},{"content":"Remove retained particles (lime, cement) using cotton bud or forceps","children":[],"payload":{"tag":"li","lines":"92,94"}}],"payload":{"tag":"h3","lines":"88,89"}},{"content":"Indicator test","children":[{"content":"Test pH at end of irrigation and 5 min after completion","children":[],"payload":{"tag":"li","lines":"96,97"}},{"content":"Normal tears: slightly alkaline (up to pH 7.4)","children":[],"payload":{"tag":"li","lines":"97,98"}},{"content":"Recheck pH after 20 min","children":[],"payload":{"tag":"li","lines":"98,99"}},{"content":"Repeat irrigation with another 2L if pH is still abnormal","children":[],"payload":{"tag":"li","lines":"99,100"}},{"content":"Record pH daily in severe injuries until ocular surface heals","children":[],"payload":{"tag":"li","lines":"100,102"}}],"payload":{"tag":"h3","lines":"94,95"}}],"payload":{"tag":"h2","lines":"70,71"}},{"content":"Acute: all injuries","children":[{"content":"Topical antibiotics (e.g., preservative-free chloramphenicol 0.5%, 4&#xd7;/day)","children":[],"payload":{"tag":"li","lines":"104,105"}},{"content":"Topical cycloplegia (e.g., cyclopentolate 1%, 3&#xd7;/day or atropine 1&#xd7;/day)","children":[],"payload":{"tag":"li","lines":"105,106"}},{"content":"Subconjunctival mydricaine for posterior synechiae","children":[],"payload":{"tag":"li","lines":"106,107"}},{"content":"Topical lubricants (e.g., preservative-free carmellose 1%) every 1&#x2013;4 hours","children":[],"payload":{"tag":"li","lines":"107,108"}},{"content":"Liquid paraffin at night","children":[],"payload":{"tag":"li","lines":"108,109"}},{"content":"Oral analgesia (e.g., paracetamol &#xb1; codeine)","children":[],"payload":{"tag":"li","lines":"109,110"}},{"content":"Prefer preservative-free medications","children":[],"payload":{"tag":"li","lines":"110,112"}}],"payload":{"tag":"h2","lines":"102,103"}},{"content":"Acute: severe injuries","children":[{"content":"Consider admission if Dua grade II or higher (mandatory for IV/V)","children":[],"payload":{"tag":"li","lines":"114,115"}},{"content":"Topical glucocorticoids (e.g., prednisolone 0.5&#x2013;1%, &#x2265;4&#xd7;/day, &lt;10 days)","children":[],"payload":{"tag":"li","lines":"115,116"}},{"content":"Topical ascorbic acid (10% sodium ascorbate up to 2-hourly, &lt;10 days)","children":[],"payload":{"tag":"li","lines":"116,117"}},{"content":"Oral ascorbic acid (1g twice daily)","children":[],"payload":{"tag":"li","lines":"117,118"}},{"content":"Systemic tetracyclines:","children":[{"content":"Doxycycline 50&#x2013;100 mg daily","children":[],"payload":{"tag":"li","lines":"119,120"}},{"content":"Oxytetracycline 500 mg 4&#xd7;/day for 3 months","children":[],"payload":{"tag":"li","lines":"120,121"}},{"content":"Contraindications: children &lt;12, pregnancy/breastfeeding, hepatic/renal issues","children":[],"payload":{"tag":"li","lines":"121,122"}}],"payload":{"tag":"li","lines":"118,122"}},{"content":"Ascorbic acid aids collagen formation and free radical scavenging","children":[],"payload":{"tag":"li","lines":"122,123"}},{"content":"Doxycycline inhibits proteinases and supports healing","children":[],"payload":{"tag":"li","lines":"123,124"}},{"content":"Less common options:","children":[{"content":"Topical sodium citrate 10% (painful but inhibits collagenases)","children":[],"payload":{"tag":"li","lines":"125,126"}},{"content":"Anterior chamber paracentesis and buffered phosphate replacement","children":[],"payload":{"tag":"li","lines":"126,128"}}],"payload":{"tag":"li","lines":"124,128"}}],"payload":{"tag":"h2","lines":"112,113"}},{"content":"Table 3.6 Strong acids and alkalis in common use","children":[{"content":"<table data-lines=\"130,142\">\n<thead data-lines=\"130,131\">\n<tr data-lines=\"130,131\">\n<th>Substance</th>\n<th>Chemical</th>\n<th>pH</th>\n</tr>\n</thead>\n<tbody data-lines=\"132,142\">\n<tr data-lines=\"132,133\">\n<td><strong>Common alkalis</strong></td>\n<td></td>\n<td></td>\n</tr>\n<tr data-lines=\"133,134\">\n<td>Oven cleaning fluid</td>\n<td>Sodium hydroxide</td>\n<td>14</td>\n</tr>\n<tr data-lines=\"134,135\">\n<td>Drain cleaning fluid</td>\n<td>Sodium/Potassium hydroxide</td>\n<td>14</td>\n</tr>\n<tr data-lines=\"135,136\">\n<td>Plaster</td>\n<td>Calcium hydroxide</td>\n<td>14</td>\n</tr>\n<tr data-lines=\"136,137\">\n<td>Fertilizers (some)</td>\n<td>Ammonium hydroxide</td>\n<td>13</td>\n</tr>\n<tr data-lines=\"137,138\">\n<td><strong>Common acids</strong></td>\n<td></td>\n<td></td>\n</tr>\n<tr data-lines=\"138,139\">\n<td>Battery fluid</td>\n<td>Sulfuric acid</td>\n<td>1</td>\n</tr>\n<tr data-lines=\"139,140\">\n<td>Lavatory cleaner</td>\n<td>Sulfuric acid</td>\n<td>1</td>\n</tr>\n<tr data-lines=\"140,141\">\n<td>Bleach</td>\n<td>Sodium hypochlorite</td>\n<td>1</td>\n</tr>\n<tr data-lines=\"141,142\">\n<td>Pool cleaning fluid</td>\n<td>Sodium/Calcium hypochlorite</td>\n<td>1</td>\n</tr>\n</tbody>\n</table>","children":[],"payload":{"tag":"table","lines":"130,142"}}],"payload":{"tag":"h2","lines":"128,129"}}],"payload":{"tag":"h1","lines":"68,69"}},{"content":"Acute: injuries with increased IOP","children":[{"content":"Acetazolamide 250 mg 4&#xd7;/day","children":[],"payload":{"tag":"li","lines":"145,146"}},{"content":"&#xb1; Topical &#x3b2;-blocker (e.g., preservative-free timolol 0.5%, 2&#xd7;/day)","children":[],"payload":{"tag":"li","lines":"146,148"}}],"payload":{"tag":"h1","lines":"143,144"}},{"content":"Long-term: complicated cases","children":[{"content":"Poor corneal healing","children":[{"content":"Treat as persistent epithelial defects","children":[],"payload":{"tag":"li","lines":"152,153"}},{"content":"Surgical options:","children":[{"content":"Amniotic membrane (AM) transplantation","children":[],"payload":{"tag":"li","lines":"154,155"}},{"content":"Amnion carrier devices (e.g., ProKera&#xae;, OmniLenz&#x2122;)","children":[],"payload":{"tag":"li","lines":"155,156"}},{"content":"Limbal stem cell transplantation","children":[],"payload":{"tag":"li","lines":"156,158"}}],"payload":{"tag":"li","lines":"153,158"}}],"payload":{"tag":"h2","lines":"150,151"}},{"content":"Obliterated fornices and pseudopterygium","children":[{"content":"Consider:","children":[{"content":"Pseudopterygium excision + conjunctival autograft or AM","children":[],"payload":{"tag":"li","lines":"161,162"}},{"content":"Anti-proliferatives (e.g., intraoperative mitomycin C)","children":[],"payload":{"tag":"li","lines":"162,163"}},{"content":"Forniceal reconstructive surgery","children":[],"payload":{"tag":"li","lines":"163,164"}},{"content":"Division of symblepharon","children":[],"payload":{"tag":"li","lines":"164,165"}},{"content":"Mucous membrane or amniotic membrane grafting (AMG)","children":[],"payload":{"tag":"li","lines":"165,167"}}],"payload":{"tag":"li","lines":"160,167"}}],"payload":{"tag":"h2","lines":"158,159"}},{"content":"Corneal opacification","children":[{"content":"Consider:","children":[{"content":"Limbal epithelial stem cell transplantation","children":[],"payload":{"tag":"li","lines":"170,171"}},{"content":"Penetrating keratoplasty (PK) if tear film adequate","children":[],"payload":{"tag":"li","lines":"171,172"}},{"content":"Keratoprosthesis for severe bilateral cases","children":[],"payload":{"tag":"li","lines":"172,173"}}],"payload":{"tag":"li","lines":"169,173"}}],"payload":{"tag":"h2","lines":"167,168"}}],"payload":{"tag":"h1","lines":"148,149"}}]},null)</script>
</body>
</html>
